Replies to post #15551 on GTC Biotherapeutics (fka GTCB)

[oldacct]

No one is going to put up more money until the
results on Atryn are known. In this financial
market Cox is not exactly in the driver's seat,
unless a new white knight comes along, which is
doubtful. It appears that Ovation has placed their
gamble and is willing to wait for the FDA.

Frankly, I am surprised that LFB doesn't just
wait for BK and pick up the pieces for nothing,
although Termeer might enter the picture when he
gets something for nothing.

[jessellivermore]

Dear cleif,

We all must face reality. Much as your speculations are tantilising they are not likely under current circumstances.
The reality is LFB is offering a loan of $15 Mil for six months at 8.5%. The loan is covered by GTC shares which LFB will concede a value of 31 cents, + some call warrants at 31 cents. Since the market currently says GTC is only worth about $11 Mil, ie less than the value of the loan, and the share price is currently around 11 cents and LFB has agreed to concede a value almost 300% the current PPS, why in the world if the deal fell through would LFB offer a better deal. At that time they could buy the same number of shares at one third the price, or for that matter at least in theory "buy the company" for less than the amount of loan.

I concur with management Re the LFB deal. It may not be all that appetising, but letting the company go without a deal is much riskier, the deal at present represents our best chance. If you do not agree with management probably your best option is the Dew solution. Sell and move on.

Regard JL